The store will not work correctly when cookies are disabled.
(E)-N'-(3,5-dichlorophenyl)-2-(5-methylisoxazol-3-yl)-2-oxoacetohydrazonoyl cyanide
ID: ALA3593480
PubChem CID: 71712136
Max Phase: Preclinical
Molecular Formula: C13H8Cl2N4O2
Molecular Weight: 323.14
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C(=O)/C(C#N)=N/Nc2cc(Cl)cc(Cl)c2)no1
Standard InChI: InChI=1S/C13H8Cl2N4O2/c1-7-2-11(19-21-7)13(20)12(6-16)18-17-10-4-8(14)3-9(15)5-10/h2-5,17H,1H3/b18-12+
Standard InChI Key: MRQAHBHMDCPCKT-LDADJPATSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.7945 -7.8036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2346 -2.4107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5408 -5.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3272 -7.4918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1944 -3.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5445 -6.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8509 -5.8560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.7379 -6.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18 16 1 0
3 11 1 0
5 1 1 0
17 8 2 0
10 14 2 0
9 5 2 0
13 6 3 0
20 2 1 0
8 7 1 0
8 9 1 0
11 12 2 0
14 3 1 0
20 17 1 0
16 12 1 0
4 18 2 0
16 15 2 0
12 10 1 0
5 19 1 0
2 4 1 0
19 20 2 0
18 13 1 0
14 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.14 | Molecular Weight (Monoisotopic): 322.0024 | AlogP: 3.46 | #Rotatable Bonds: 4 |
Polar Surface Area: 91.28 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.41 | CX Basic pKa: ┄ | CX LogP: 4.28 | CX LogD: 2.56 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.53 | Np Likeness Score: -1.92 |
References
1. Ye N, Zhu Y, Chen H, Liu Z, Mei FC, Wild C, Chen H, Cheng X, Zhou J.. (2015) Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists., 58 (15): [PMID:26151319] [10.1021/acs.jmedchem.5b00635] |